网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
Capn4和P52在结肠癌中的表达及意义
作者:王东华  贾喜花  郑淑君  赵霞  张丙信  王晓博 
单位:保定市第一中心医院 肿瘤内科, 河北 保定 071000
关键词:Capn4 P52 结肠癌 免疫组织化学 
分类号:R735.3
出版年·卷·期(页码):2017·36·第七期(925-928)
摘要:

目的:探讨钙蛋白酶小亚基-1(Capn4)和核转录因子-κB2(p52)在结肠癌中的表达及临床意义,以及两者在结肠癌发生、发展过程中的相关性。方法:应用免疫组织化学方法检测70例结肠癌组织及35例癌旁正常结肠组织中Capn 4和p52的表达情况,并分析Capn 4和p52的表达与结肠癌临床病理特征的关系。结果:Capn 4及p52在结肠癌(74.3%、70.0%)中的表达明显高于癌旁正常结肠组织(22.9%、31.4%)(P<0.05),两者在结肠癌组织中表达与结肠癌的浸润深度、TNM分期以及有无淋巴结转移密切相关(P<0.05),与患者年龄、性别、分化程度无关(P>0.05),并且两者在结肠癌的发生发展中可能存在相关性(r=0.869,P<0.05)。结论:Capn 4和p52在结肠癌组织中高表达,提示两者可能与结肠癌的浸润、转移有关。两者的表达呈正相关,提示Capn 4可能通过NF-κB通路的非经典途径起作用。

Objective: To investigate the expression of calpain small subunit-1 (Capn4) and nuclear transcription factor-kappaB2 (p52) in colon cancer and its clinical significance.The correlation between Capn4 and p52 involving the development and progression of colon cancer is investigated. Methods: The expressions of Capn4 and p52 in seventy cases with colon cancer tissue and Thirty-five cases with normal colon mucosa tissueare detected by immunohistochemistry. And to analyze the relationship between the expression of them and clinicopathological features of colon cancer. Results: The expression of Capn4 and p52 in colon cancer tissue (74.3%,70.0%,respectively)is significantly higher than normal colon mucosa tissue(22.9%,31,4%,respectively)(P<0.05). The expression of Capn4 and p52 is significantly correlated with depth of infiltration,TNM staging and lymph node metastasis (P<0.05),but there is not correlated with age,sex and differentiation grade of colon cancer(P>0.05). And the expression of Capn4 and p52 is positively correlated(r=0.869,P<0.05).Conclusion: In colon cancer,Capn4 and p52 are high-expression,suggesting that Capn4 and p52 may involve the development and progression of colon cancer.The expression of both is positive correlated,suggesting that Capn4 may play a role in colon cancer by non-canonical NF-kappaB signaling pathway.

参考文献:

[1] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2015[J].CA Cancer J Clin,2015,65(1):5-29.
[2] GOLL D E,THOMPSON V F,LI H,et al.The calpain system[J].Physiol Rev,2003,83(3):731-801.
[3] 齐曾鑫,蔡加君,姚瑜,等.钙蛋白酶的研究进展[J].中国临床神经科学,2013,21(4):456-462.
[4] ZHANG C,BAI D S,HUANG X Y,et a1.Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma[J].PLoS One,2013,8(1):e54619.
[5] ZHUANG Q,QIAN X,CAO Y,et al.Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma[J].J Int Med Res,2014,42(2):282-291.
[6] WANG G S,HUANG Y G,LI H,et al.ERK/CANP rapid signaling mediates 17beta-estradiol-induced proliferation of human breast cancer cell line MCF-7 cells[J].Int J Clin Exp Med,2014,7(1):156-162.
[7] ZHENG P C,CHEN X,ZHU H W,et al.Capn 4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metallo-proteinase 2 expression[J].Cancer Sci,2014,105(6):630-638.
[8] SUN S C.The noncanonical NF-κB pathway[J].Immunol Rev,2012,246(1):125-140.
[9] SUN S C.Non-canonical NF-κB signaling pathway[J].Cell Res,2011,21(1):71-85.
[10] KARIN M,CAO Y,GRETEN F R,et al.NF-kappaB in cancer:from innocent bystander to majorculprit[J].Nat Rev Cancer,2002,2(4):301-310.
[11] 刘志,闫威,赵春清,等.血管内皮生长因子与细胞增殖核抗原在直肠癌组织中的表达及临床意义[J].中国综合临床,2014,30(11):1197-1199.
[12] 曹伟,许贤林,何小舟.钙蛋白酶小亚基1在细胞凋亡、细胞周期及肿瘤中作用机制的研究进展[J].中国医药生物技术,2015,10(4):323-325.
[13] 骆永富,曾之耀,王湘英.NF-κB在结肠癌组织中的表达及临床意义[J].中国保健营养,2015,11(9):54-55.
[14] DIMITRAKOPOULOS F I,ANTONACOPOULOU A G,KOTTOROU A,et al.NSCLC and the alternative pathway of NF-κB:Uncovering an unknown relation[J].Virchows Archiv,2012,460(5):515-523.
[15] 谭林,刘诗权,覃蒙斌,等.NIBP在结肠癌NF-κB非经典激活通路中的作用其临床意义[J].世界华人消化杂志,2015,23(8):1238-1246.
[16] LI Y,ZHANG Z,ZHOU X,et al.The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation Involving MEKK2/ERK1/2/Capn4 signaling[J].Cancer Lett,2014,355(2):288-296.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 750183 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541